GB9115250D0 - Process - Google Patents

Process

Info

Publication number
GB9115250D0
GB9115250D0 GB919115250A GB9115250A GB9115250D0 GB 9115250 D0 GB9115250 D0 GB 9115250D0 GB 919115250 A GB919115250 A GB 919115250A GB 9115250 A GB9115250 A GB 9115250A GB 9115250 D0 GB9115250 D0 GB 9115250D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919115250A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to MX9100581A priority Critical patent/MX9100581A/en
Publication of GB9115250D0 publication Critical patent/GB9115250D0/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB919115250A 1990-08-09 1991-07-16 Process Pending GB9115250D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9100581A MX9100581A (en) 1990-08-09 1991-08-08 PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process

Publications (1)

Publication Number Publication Date
GB9115250D0 true GB9115250D0 (en) 1991-08-28

Family

ID=10680406

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909017479A Pending GB9017479D0 (en) 1990-08-09 1990-08-09 Process
GB919115250A Pending GB9115250D0 (en) 1990-08-09 1991-07-16 Process

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB909017479A Pending GB9017479D0 (en) 1990-08-09 1990-08-09 Process

Country Status (15)

Country Link
EP (1) EP0495948A1 (en)
JP (1) JPH05501728A (en)
KR (1) KR920702357A (en)
CN (1) CN1058965A (en)
AU (1) AU8309091A (en)
CA (1) CA2047249A1 (en)
CS (1) CS88692A3 (en)
FI (1) FI921319A0 (en)
GB (2) GB9017479D0 (en)
HU (1) HUT60490A (en)
IE (1) IE912406A1 (en)
IL (1) IL98833A0 (en)
PT (1) PT98607A (en)
WO (1) WO1992002508A1 (en)
ZA (1) ZA915567B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
US5484955A (en) * 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
US6608048B2 (en) 2000-03-28 2003-08-19 Wyeth Holdings Tricyclic protein kinase inhibitors
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
RS65632B1 (en) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-pure agonists of guanylate cyclase c, method of making and using same
RS56362B1 (en) 2013-09-16 2017-12-29 Astrazeneca Ab Therapeutic polymeric nanoparticles and methods of making and using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
BG92674A (en) * 1989-08-11 1993-12-24 David Roberts METHOD FOR OBTAINING QUINOLINE DERIVATIVES

Also Published As

Publication number Publication date
FI921319A (en) 1992-03-26
CA2047249A1 (en) 1992-02-10
FI921319A0 (en) 1992-03-26
ZA915567B (en) 1992-07-29
JPH05501728A (en) 1993-04-02
PT98607A (en) 1992-06-30
GB9017479D0 (en) 1990-09-26
AU8309091A (en) 1992-03-02
KR920702357A (en) 1992-09-03
HU9200933D0 (en) 1992-05-28
CN1058965A (en) 1992-02-26
IL98833A0 (en) 1992-07-15
WO1992002508A1 (en) 1992-02-20
EP0495948A1 (en) 1992-07-29
HUT60490A (en) 1992-09-28
CS88692A3 (en) 1992-10-14
IE912406A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
GB9113287D0 (en) Process
EP0475731A3 (en) Development process
GB9022127D0 (en) Process
GB9022787D0 (en) Process
AP9100251A0 (en) Process
GB9115250D0 (en) Process
GB9009000D0 (en) Novel process
HU913311D0 (en) Deparaffinizating process
GB9026926D0 (en) Novel process
EP0443796A3 (en) Development process
GB9004390D0 (en) Process
GB9014851D0 (en) Process
GB9013699D0 (en) New process
RO105801B1 (en) Ppreparation process for alhylcyclohexanols
GB9014234D0 (en) Preparation process
GB9026426D0 (en) Process
HU906304D0 (en) Poisonless blue-chromating process
GB9021664D0 (en) Process
GB9000907D0 (en) Process
GB9011814D0 (en) Process
GB9023291D0 (en) Process
GB9023300D0 (en) Process
GB9025680D0 (en) Process
GB9021662D0 (en) Process
GB9026477D0 (en) Process